Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis

被引：63
|
作者：
Vicari, AM
Ciceri, F
Folli, F
Lanzi, R
Colombo, B
Comi, G
Camba, L
机构：
[1] Hosp San Raffaele, Dept Med, I-20132 Milan, Italy
[2] Hosp San Raffaele, Dept Haematol, I-20132 Milan, Italy
[3] Hosp San Raffaele, Unita Malattie Metab, I-20132 Milan, Italy
[4] Hosp San Raffaele, IRCCS, Dept Neurol, I-20132 Milan, Italy
来源：
LEUKEMIA | 1998年 / 12卷 / 03期
关键词：
D O I：
10.1038/sj.leu.2400915
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：441 / 442
页数：2
相关论文
共 50 条
  • [21] Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
    Mathews, Vikram
    Chendamarai, Ezhilarasi
    George, Biju
    Viswabandya, Auro
    Srivastava, Alok
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2011, 3 (01)
  • [22] Multiple sclerosis and mitoxantrone treatment-related leukemia: A single center experience
    Lynn, DJ
    Blum, W
    Cataland, S
    Rammohan, KW
    NEUROLOGY, 2006, 66 (05) : A31 - A31
  • [23] INDUCTION OF REMISSION IN ACUTE PROMYELOCYTIC LEUKEMIA WITH MITOXANTRONE
    MITTELMAN, A
    RIEBER, E
    FRIEDLAND, ML
    ARLIN, ZA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) : 81 - 82
  • [24] Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis
    Ammatuna, Emanuele
    Montesinos, Pau
    Hasan, Syed Khizer
    Ramadan, Safaa M.
    Esteve, Jordi
    Hubmann, Maximillian
    Pagoni, Maria
    Grimwade, David
    Angel Sanz, Miguel
    Lo-Coco, Francesco
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (04): : 621 - 625
  • [25] Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone
    Martinelli, V.
    Cocco, E.
    Capra, R.
    Salemi, G.
    Gallo, P.
    Capobianco, M.
    Pesci, I.
    Ghezzi, A.
    Pozzilli, C.
    Lugaresi, A.
    Bellantonio, P.
    Amato, M. P.
    Grimaldi, L. M.
    Trojano, M.
    Mancardi, G. L.
    Bergamaschi, R.
    Gasperini, C.
    Rodegher, M.
    Straffi, L.
    Ponzio, M.
    Comi, G.
    NEUROLOGY, 2011, 77 (21) : 1887 - 1895
  • [26] ARSENIC TRIOXIDE AS THE FIRST LINE THERAPY FOR PATIENTS WITH SECONDARY MITOXANTRONE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA ON THE BACKGROUND OF MULTIPLE SCLEROSIS
    Lobanova, T.
    Troizkaya, V.
    Sokolov, A.
    Kravchenko, S.
    Plastilina, L.
    Gavrilina, O.
    Sidorova, A.
    Galstyan, G.
    Parovichnikova, E.
    HAEMATOLOGICA, 2016, 101 : 684 - 684
  • [27] Mitoxantrone in the Treatment of Multiple Sclerosis: a Single-Center Experience
    Taskapilioglu, Ozlem
    Sener, Deniz Kamaci
    Turan, Asli Bahar
    Yurtogullari, Sukran
    Tutuncu, Ahmet
    Gullulu, Sumeyye
    Ocakoglu, Gokhan
    Turan, Omer Faruk
    TURKISH JOURNAL OF NEUROLOGY, 2012, 18 (02) : 62 - 66
  • [28] Treatment of acute promyelocytic leukemia:: A single institution experience
    Ruiz-Argüelles, GJ
    Morales-Toquero, A
    Gómez-Rangel, JD
    López-Martínez, B
    Ruiz-Delgado, GJ
    Reyes-Núñez, V
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2005, 57 (03): : 415 - 419
  • [29] Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia
    Zhou, Jin
    Zhang, Yingmei
    Li, Jinmei
    Li, Xiaoxia
    Hou, Jinxiao
    Zhao, Yanqiu
    Liu, Xiuhua
    Han, Xueying
    Hu, Longhu
    Wang, Shuye
    Zhao, Yanhong
    Zhang, Ying
    Fan, Shengjin
    Lv, Chengfang
    Li, Limin
    Zhu, Lingling
    BLOOD, 2010, 115 (09) : 1697 - 1702
  • [30] Use of Arsenic Trioxide As a First-Line Single Agent in the Treatment of Acute Promyelocytic Leukemia
    Keyhani, Manoutchehr
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (02) : 217 - 217
12345